Towards bio-compatible magnetic nanoparticles: Immune-related effects, in-vitro internalization, and in-vivo bio-distribution of zwitterionic ferrite nanoparticles with unexpected renal clearance

2021 ◽  
Vol 582 ◽  
pp. 678-700 ◽  
Author(s):  
Anna M. Ferretti ◽  
Sandro Usseglio ◽  
Sara Mondini ◽  
Carmelo Drago ◽  
Rosa La Mattina ◽  
...  
Keyword(s):  
Magnetic Nanoparticles ◽  
Renal Clearance ◽  
Ferrite Nanoparticles

scholarly journals Use of Magnetic Nanoparticles as Targeted Therapy: Theranostic Approach to Treat and Diagnose Cancer

2017 ◽  
Vol 2017 ◽  
pp. 1-8 ◽  
Author(s):  
Arif Malik ◽  
Tariq Tahir Butt ◽  
Sara Zahid ◽  
Fatima Zahid ◽  
Sulayman Waquar ◽  
...  
Keyword(s):  
Magnetic Nanoparticles ◽  
Cancer Imaging ◽  
Metastatic Cancer ◽  
Therapeutic Index ◽  
Direct Access ◽  
Human Beings ◽  
Clinical Practices ◽  
Proliferating Cells

The metastasis of cancer epitomizes the diagnostic and therapeutic challenge as a result of cancer heterogeneity. To overcome the uncontrolled growth of the proliferating cells, nanosystems have been developed and have undergone many preclinical trials both in vitro and in vivo and many practices have been further applied clinically on human beings. In practice, magnetic nanoparticles- (MNPs-) based systems following the application of Fe3O4 bound antitumor drug have shown an enhanced therapeutic index in comparison with conventional chemotherapy ensuring the significant decline in nanosystems’ toxicity. A number of improved strategies employing nanoparticle engineering have been in practice for upgrading selectivity of metastatic cells and to have direct access to poorly manageable tumor regions. Targeted nanoparticle therapy paving the way towards tumor biomarkers and tissue specific cancer stages provides effective strategies for nonaccessible tumor regions, thus leading to the tangible modification in the history of cancer world. An infinite number of targets have been exploited for surface receptor specificity to distinct types of nanoparticles and are presently enduring clinical practices both in vitro and in vivo. The aim of this review is to take into view current nanotechnology-based research in cancer imaging for diagnosis and treatment. Several commercially available magnetic nanoparticles-based systems applied as contrast agents for metastatic cancer imaging and treatment via hyperthermia have also been focused on.

scholarly journals Biocompatibility and Toxicity of Magnetic Nanoparticles in Regenerative Medicine

2012 ◽  
Vol 2012 ◽  
pp. 1-11 ◽  
Author(s):  
H. Markides ◽  
M. Rotherham ◽  
A. J. El Haj
Keyword(s):  
Magnetic Nanoparticles ◽  
Regenerative Medicine ◽  
Effective Means ◽  
Basic Research ◽  
Normal Function ◽  
Iron Oxide Core ◽  
Therapeutic Doses

Regenerative medicine is a pioneering field aimed at restoring and regenerating the function of damaged cells, organs and tissues in order to establish normal function. It demands the cross communication of disciplines to develop effective therapeutic stem cell based therapies. Nanotechnology has been instrumental in the development and translation of basic research to the clinically relevant therapies. In particular, magnetic nanoparticles (MNPs) have been applied to tag, track and activate stem cells offering an effective means of monitoringin vitroandin vivobehaviour. MNPs are comprised of an iron oxide core with a biocompatible biological polymer. Safety is an issue of constant concern and emphasises on the importance of investigating the issue of toxicity. Any indication of toxicity can ultimately limit the therapeutic efficiency of the therapy. Toxicity is highly dependent on the physical, chemical and structural properties of the MNP itself as well as dose and intended use. Fewin vitrostudies have reported adverse effects of MNP on cells atin vitroin therapeutic doses. However, long termin vivostudies have not been studied as extensively. This review aims to summarise current research in this topic highlighting commonly used toxicity assays to investigate this.

Cit/CuS@Fe3O4-based and enzyme-responsive magnetic nanoparticles for tumor chemotherapy, photothermal, and photodynamic therapy

2016 ◽  
Vol 31 (7) ◽  
pp. 1010-1025 ◽  
Author(s):  
Xiali Zhu ◽  
Heqing Huang ◽  
Yingjie Zhang ◽  
Huijuan Zhang ◽  
Lin Hou ◽  
...  
Keyword(s):  
Photodynamic Therapy ◽  
Magnetic Nanoparticles ◽  
Drug Release ◽  
Degradation Mechanism ◽  
Great Promise ◽  
The Subject ◽  
The Individual ◽  
Mcf 7

Safe and efficient drug delivery in a controllable fashion, especially remote and repeatable switch of on-demand drug release, is the subject of widespread attention. A kind of magnetic nanoparticles (DOX-Cit/CuS@Fe3O4-NPs) simultaneously consisted of Cit/CuS@Fe3O4 and doxorubicin (DOX) was presented. The drug release from DOX-Cit/CuS@Fe3O4-NPs could be successfully triggered by the presence of gelatinase, showing great promise for tumor-targeted drug release through an enzymatic degradation mechanism. Compared with free DOX, DOX-Cit/CuS@Fe3O4-NPs could not only specially deliver Cit/CuS@Fe3O4 and DOX into MCF-7 cells, but also could greatly improve the quantity of ROS produced in MCF-7 cells under of 980 nm laser irradiation. DOX-Cit/CuS@Fe3O4-NPs also had highly selective accumulation at tumor tissue of S180 tumor-bearing mice, which were along with a magnet near the tumor site. Furthermore, when combined with NIR laser irridation, DOX-Cit/CuS@Fe3O4-NPs showed a higher antitumor efficacy than the individual therapies in vitro and in vivo. This study showed that DOX-Cit/CuS@Fe3O4-NPs could be used as a platform for tumor chemotherapy, photothermal and photodynamic therapy.

Synthesis, characterization, in vitro and in vivo studies of dextrin-coated zinc-iron ferrite nanoparticles (Zn0.5Fe0.5Fe2O4) as contrast agent in MRI

2015 ◽  
Vol 120 (3) ◽  
pp. 1189-1196 ◽  
Author(s):  
T. Zare ◽  
M. Lotfi ◽  
H. Heli ◽  
N. Azarpira ◽  
A. R. Mehdizadeh ◽  
...  
Keyword(s):  
Contrast Agent ◽  
Ferrite Nanoparticles ◽  
In Vivo Studies ◽  
Iron Ferrite

scholarly journals In vitro methods for the study of microbial biofilms

2011 ◽  
Vol 1 (1) ◽  
pp. 031-040 ◽  
Keyword(s):  
Ferrite Nanoparticles ◽  
In Vitro Assays ◽  
Confocal Laser ◽  
Microbial Biofilm ◽  
In Vivo Models ◽  
Microbial Biofilms ◽  
Human Pathology ◽  
Biofilm Development

The emergence of microbial biofilm related infections (bacterial and fungal) has a significant impact for the human pathology in the entire world. The understanding of microbial infections related to the biofilm development on tissues or indwelling devices was possible by using different qualitative and quantitative in vitro assays, in continuous and discontinuous systems, as well as in vivo models. A necessary step for obtaining more standardized, reliable and comparable results among different laboratories is the simplification of the available techniques used for investigating the biofilm formation and properties, including the biofilms susceptibility to antibiotics. The aim of the present study was to exemplify a series of available methods for the investigation of in vitro microbial biofilms developed on inert substrata, as well as coated with ferrite nanoparticles, using as experimental model a Sacharomyces cerevisiae strain. Microbial biofilm architecture was directly examined by two microscopy techniques (inverted microscopy and confocal laser microscopy scanning). The in vitro study of the influence of suspended ferrite nanoparticles on planktonic cells growth, adherence and consecutive biofilm development on inert substrata was performed by using a simple microtiter method.

Preparation of Magnetic Drug Loaded Nanoparticles and Its Anticancer Efficacy Against Nasopharyngeal Carcinoma Cells

2021 ◽  
Vol 13 (5) ◽  
pp. 857-863
Author(s):  
Jingjing Chen ◽  
Cheng Kang
Keyword(s):  
Magnetic Nanoparticles ◽  
Nasopharyngeal Carcinoma ◽  
Therapeutic Effect ◽  
Inhibitory Effect ◽  
Antagonistic Effect ◽  
Anticancer Efficacy ◽  
Normal Tissues ◽  
Chemotherapy Agent

As an important drug for the treatment of cancer, cis-diamine dichloroplatinum (CDDP) has poor solubility and antagonistic effect when it is used as a chemotherapy agent alone, leading to the insufficient dose in actual administration. In order to solve the above problems, increase the targeting property of CDDP carrier and prolong the half-life period of CDDP’s sustained-release, it is necessary to design a magnetic nano-carrier for CDDP with magnetic targeting function to reduce the damage of CDDP to normal tissues in vivo and improve the therapeutic effect of cancer. Carboxymethyl chitosan (CMCS) is used to directly coat oleic acid (OA)-modified Fe3O4 nanoparticles (OA-Fe3O4 NPs) to create the nano-scale CMCS magnetic nanoparticles (CMCS/OA-Fe2O3 NPs), and CDDP loaded magnetic nanoparticles (CMCS/OA-Fe2O3 NPs/CDDP) are prepared by the bonding interaction between carboxyl groups on the surface of CMCS and the anticancer drug CDDP. The magnetic drug loaded nanoparticles are characterized, and the results show that the magnetic nanoparticles are successfully embedded in CMCS and loaded with CDDP, with the drug load of 43.65 ± 2.37%. MTT assay, flow cytometry and invasion assay are applied to evaluate the inhibitory effect of magnetic drug loaded nanoparticles to nasopharyngeal carcinoma (NPC) cells HNE-1. The results suggest that the magnetic drug loaded nanoparticles successfully prepared have significant inhibitory effect on HNE-1 cells in vitro. Therefore, the magnetic drug loaded nanoparticles prepared have a good therapeutic effect on NPC.

scholarly journals Assessment of Immunotoxicity of Dextran Coated Ferrite Nanoparticles in Albino Mice

2015 ◽  
Vol 2015 ◽  
pp. 1-10 ◽  
Author(s):  
Santhakumar Syama ◽  
Viswanathan Gayathri ◽  
Parayanthala Valappil Mohanan
Keyword(s):  
Antioxidant Defense ◽  
Defense Mechanism ◽  
Cellular Level ◽  
Ferrite Nanoparticles ◽  
Antioxidant Parameters ◽  
Immunological Reactions ◽  
Albino Mice ◽  
And Oxidative Stress

In this study, dextran coated ferrite nanoparticles (DFNPs) of size <25 nm were synthesized, characterized, and evaluated for cytotoxicity, immunotoxicity, and oxidative stress by in vitro and in vivo methods. Cytotoxicity was performed in vitro using splenocytes with different concentrations of DFNPs. Gene expression of selected cytokines (IL-1, IL-10, and TNF β) secretion by splenocytes was evaluated. Also, 100 mg of DFNPs was injected intraperitoneally to 18 albino mice for immunological stimulations. Six animals each were sacrificed at the end of 7, 14, and 21 days. Spleen was subjected to immunotoxic response and liver was analyzed for antioxidant parameters (lipid peroxidation, reduced glutathione, glutathione peroxidase, superoxide dismutase, and glutathione reductase). The results indicated that DFNPs failed to induce any immunological reactions and no significant alternation in antioxidant defense mechanism. Also, mRNA expression of the cytokines revealed an increase in IL-10 expression and subsequent decreased expression of IL-1 and TNF β. Eventually, DNA sequencing of liver actin gene revealed base alteration in nonconserved regions (10–20 bases) of all the treated groups when compared to control samples. Hence, it can be concluded that the DFNPs were nontoxic at the cellular level and nonimmunotoxic when exposed intraperitoneally to mice.

Sign in / Sign up

Export Citation Format

Share Document